Related references
Note: Only part of the references are listed.Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050
Sophie Pilleron et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Informing Patients About Expected Outcomes: The Efficacy-Effectiveness Gap
Arnoud J. Templeton et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The world cancer patient population (WCPP): An updated standard for international comparisons of population-based survival
Adalberto Miranda-Filho et al.
CANCER EPIDEMIOLOGY (2020)
Adjuvant treatment of endometrial cancer today
Yoichi Aoki et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2020)
Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression: A Randomized Clinical Trial
Hiroyuki Nomura et al.
JAMA ONCOLOGY (2019)
Cancer statistics for adults aged 85 years and older, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial
Michel Fabbro et al.
GYNECOLOGIC ONCOLOGY (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian Cancer in the International ROSiA Study
Frederic Selle et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology
Supriya G. Mohile et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Summary
Supriya G. Mohile et al.
JOURNAL OF ONCOLOGY PRACTICE (2018)
Can Vulnerable Elders Survey-13 predict the impact of frailty on chemotherapy in elderly patients with gynaecological malignancies?
Annamaria Ferrero et al.
MEDICINE (2018)
Disparities in care for elderly women with endometrial cancer adversely effects survival
Anna Torgeson et al.
GYNECOLOGIC ONCOLOGY (2017)
Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study
Vivian E. von Gruenigen et al.
GYNECOLOGIC ONCOLOGY (2017)
Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women
Weiping Wang et al.
BMC CANCER (2017)
Impact of age on the safety and efficacy of bevacizumab (BEV)-containing therapy in patients (pts) with primary ovarian cancer (OC): Analyses of the OTILIA German non-interventional study on behalf of the North-Eastern German Society of Gynaecological Oncology Ovarian Cancer Working Group
A. Mustea et al.
ANNALS OF ONCOLOGY (2016)
Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: Results of a pooled analysis of three GINECO phase II trials
Fabien Tinquaut et al.
GYNECOLOGIC ONCOLOGY (2016)
Combination chemotherapy with docetaxel and carboplatin for elderly patients with endometrial cancer
Hiroyuki Yoshida et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN)
V. Launay-Vacher et al.
ANNALS OF ONCOLOGY (2015)
Treating Cancer in Older and Oldest Old Patients
G. Colloca et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer
Carol Aghajanian et al.
GYNECOLOGIC ONCOLOGY (2015)
Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236)
Linda R. Duska et al.
GYNECOLOGIC ONCOLOGY (2015)
Daily Low-Dose Cisplatin-Based Concurrent Chemoradiotherapy for the Treatment of Cervical Cancer in Patients 70 Years or Older
Shinsuke Hanawa et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2015)
Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
Ryo Kitagawa et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Management for Elderly Women With Advanced-Stage, High-Grade Endometrial Cancer
J. Alejandro Rauh-Hain et al.
OBSTETRICS AND GYNECOLOGY (2015)
International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer
Hans Wildiers et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
Sandro Pignata et al.
LANCET ONCOLOGY (2014)
Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial
C. Falandry et al.
ANNALS OF ONCOLOGY (2013)
Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium
Fabian Trillsch et al.
JOURNAL OF OVARIAN RESEARCH (2013)
Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
Martine Extermann et al.
CANCER (2012)
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Carol Aghajanian et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study
J. E. Kurtz et al.
ANNALS OF ONCOLOGY (2011)
Endometrial cancer in the oldest old: Tumor characteristics, patterns of care, and outcome
Jason D. Wright et al.
GYNECOLOGIC ONCOLOGY (2011)
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
Arti Hurria et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
Eric Pujade-Lauraine et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Seiichi Matsuo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study
Bradley J. Monk et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
Noriyuki Katsumata et al.
LANCET (2009)
Chemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidity
M. Goodheart et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged ≥70 years with advanced ovarian cancer -: a study by the AGO OVAR Germany
F. Hilpert et al.
ANNALS OF ONCOLOGY (2007)
International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency
Stuart M. Lichtman et al.
EUROPEAN JOURNAL OF CANCER (2007)
Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and leukemia group B (CALGB 9762)
SM Lichtman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer
D Hershman et al.
GYNECOLOGIC ONCOLOGY (2004)
Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis
JA Green et al.
LANCET (2001)
Share Paper
